Only about 5% of the universe is composed of normal matter that we can directly observe, while the remaining 95% is widely ...

From engineered regime changes to individual political migrations, the BJP’s rise since 2014 has been powered as much by ...

Coming off a strong 2025 with sustained momentum, 2026 is proving resilient with a solid first quarter financial performance ...

If we invest in AI's connective tissue, we can build a scientific system that matches the scale of our problems and the scope ...

Hands-free tools like phone and tablet stands are no longer a convenience—they are a necessity. Start with the scale of the ...

Q1 2026 Earnings Call April 30, 2026 8:00 AM EDTCompany ParticipantsJean-Laurent Bonnafe - MD, CEO & DirectorLars Machenil ...

Q1 2026 Earnings Call April 30, 2026 4:30 PM EDTCompany ParticipantsJoshua Kane - Vice President of Investor RelationsJason ...

Is MORN a good stock to buy? We came across a bullish thesis on Morningstar, Inc. on Countervail Capital’s Substack by Johann ...

Pearl's Head of AI Operations Mark Quinn was displaced by the same technology he now deploys at scale. That experience taught ...

Buy AAVE spot. The protocol froze rsETH markets and moved ETH markets into emergency management, stopping further contagion; ...

ReviR Therapeutics today announced a strategic investment from CureCMT to support the launch of a precision medicine platform for Charcot-Marie-Tooth disease (CMT). The platform will combine isogenic ...

Enterprise AI may have moved beyond the proof of concept phase, but many companies still seem stuck in the same place ...